ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - NYSE:ENOV - US1940141062 - Common Stock
26.83 USD
-0.34 (-1.25%)
26.83 USD
0 (0%)
Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 188 industry peers in the Health Care Equipment & Supplies industry. ENOV has a medium profitability rating, but doesn't score so well on its financial health evaluation. ENOV scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year ENOV was profitable.
ENOV had a positive operating cash flow in the past year.
In multiple years ENOV reported negative net income over the last 5 years.
Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -30.84%, ENOV perfoms like the industry average, outperforming 43.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of -67.66%, ENOV is in line with its industry, outperforming 45.21% of the companies in the same industry.
ENOV has a better Return On Invested Capital (0.12%) than 65.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 0.25%, ENOV is in the better half of the industry, outperforming 65.43% of the companies in the same industry.
ENOV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 57.19%, ENOV is in line with its industry, outperforming 55.32% of the companies in the same industry.
ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
ENOV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ENOV has more shares outstanding
ENOV has a worse debt/assets ratio than last year.
2.2 Solvency
ENOV has an Altman-Z score of 0.79. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
ENOV has a Altman-Z score of 0.79. This is comparable to the rest of the industry: ENOV outperforms 51.60% of its industry peers.
The Debt to FCF ratio of ENOV is 59.72, which is on the high side as it means it would take ENOV, 59.72 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ENOV (59.72) is better than 66.49% of its industry peers.
ENOV has a Debt/Equity ratio of 0.66. This is a neutral value indicating ENOV is somewhat dependend on debt financing.
ENOV has a Debt to Equity ratio of 0.66. This is in the lower half of the industry: ENOV underperforms 66.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.79 |
ROIC/WACC0.02
WACC7.21%
2.3 Liquidity
A Current Ratio of 2.22 indicates that ENOV has no problem at all paying its short term obligations.
With a Current ratio value of 2.22, ENOV is not doing good in the industry: 60.64% of the companies in the same industry are doing better.
A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
The Quick ratio of ENOV (1.16) is worse than 71.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
ENOV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.18% yearly.
Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 11.57% in the last year.
Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -8.73% on average per year.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
The Earnings Per Share is expected to grow by 23.19% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.87% on average over the next years. This is quite good.
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.06 indicates a reasonable valuation of ENOV.
Based on the Price/Earnings ratio, ENOV is valued cheaper than 95.21% of the companies in the same industry.
ENOV is valuated cheaply when we compare the Price/Earnings ratio to 25.07, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.51, the valuation of ENOV can be described as very cheap.
Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 96.28% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.08. ENOV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.06 | ||
| Fwd PE | 7.51 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 89.36% of the companies listed in the same industry.
ENOV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ENOV is cheaper than 70.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 67.37 | ||
| EV/EBITDA | 9.68 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ENOV's earnings are expected to grow with 13.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y12.38%
EPS Next 3Y13.12%
5. Dividend
5.1 Amount
ENOV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
26.83
-0.34 (-1.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.31%
Inst Owner Change-2.39%
Ins Owners1.19%
Ins Owner Change2.68%
Market Cap1.53B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target52.79 (96.76%)
Short Float %13.73%
Short Ratio9.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-4.75%
PT rev (3m)-11.45%
EPS NQ rev (1m)-4.99%
EPS NQ rev (3m)-5.2%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.89%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.06 | ||
| Fwd PE | 7.51 | ||
| P/S | 0.69 | ||
| P/FCF | 67.37 | ||
| P/OCF | 7.06 | ||
| P/B | 0.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.68 |
EPS(TTM)3.33
EY12.41%
EPS(NY)3.57
Fwd EY13.32%
FCF(TTM)0.4
FCFY1.48%
OCF(TTM)3.8
OCFY14.15%
SpS39.07
BVpS35.35
TBVpS-8.37
PEG (NY)0.64
PEG (5Y)N/A
Graham Number51.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.79 |
F-Score4
WACC7.21%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year74.87%
EBIT Next 3Y29.81%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 12.58% in the next year.